Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (5) , 385-390
- https://doi.org/10.1007/bf00686008
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High‐dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urineEuropean Journal of Clinical Investigation, 1991
- Glutathione and detoxificationCancer Treatment Reviews, 1990
- Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerCancer Chemotherapy and Pharmacology, 1990
- Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drugChemico-Biological Interactions, 1989
- Cisplatin pharmacokinetics: applications of a physiological modelToxicology Letters, 1988
- SERIAL DETERMINATION OF PLATINUM, PROTEIN-CONTENT AND FREE SULFHYDRYL LEVELS IN PLASMA OF PATIENTS TREATED WITH CISPLATIN OR CARBOPLATIN1988
- Reaction of platinum(II) antitumor agents with sulfhydral compounds and the implications for nephrotoxicityInorganica Chimica Acta, 1987
- KINETICS OF PLATINUM IN CANCER-PATIENTS TREATED WITH CISPLATIN AT DIFFERENT DOSES1987
- High-dose cisplatin therapy in ovarian cancer.1985
- Protective Effect of Reduced Glutathione against CIS-Dichlorodiammine Platinum (II)–Induced Nephrotoxicity and Lethal ToxicityTumori Journal, 1983